Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies

Patients with diffuse large cell lymphoma who have an adequate vitamin D supply derive significantly more benefit from immuno-chemotherapy with rituximab than patients with vitamin D deficiency; this is especially true for female patients. We have already been able to show that vitamin D increases t...

Descripción completa

Detalles Bibliográficos
Autores principales: Christofyllakis, Konstantinos, Neumann, Frank, Bewarder, Moritz, Thurner, Lorenz, Kaddu-Mulindwa, Dominic, Kos, Igor Age, Lesan, Vadim, Bittenbring, Joerg Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457932/
https://www.ncbi.nlm.nih.gov/pubmed/37630689
http://dx.doi.org/10.3390/nu15163498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457932/
https://www.ncbi.nlm.nih.gov/pubmed/37630689
http://dx.doi.org/10.3390/nu15163498

Ejemplares similares